comparemela.com
Home
Live Updates
Freya Pharma Solutions Announces Appointment of Dr. Jan van der Mooren as Chief Medical Officer, to guide its pivotal phase 3 clinical trial with Lybrido against FSIAD : comparemela.com
Freya Pharma Solutions Announces Appointment of Dr. Jan van der Mooren as Chief Medical Officer, to guide its pivotal phase 3 clinical trial with Lybrido against FSIAD
/PRNewswire/ -- Freya Pharma Solutions, a late clinical stage company focusing on the development of effective pharmaceutical therapies for women who have been...
Related Keywords
Helsinki ,
Eteläuomen Läi ,
Finland ,
United States ,
Netherlands ,
Amsterdam ,
Noord Holland ,
American ,
Marcel Wijma ,
American Psychiatric Association ,
Danone ,
Vu University Medical Center ,
European Union ,
Nutricia Research Center ,
Clinical Research ,
Freya Pharma Solutions ,
Department Of Obstetrics Gynaecology ,
Lifespring Life Sciences Communication ,
Gynaecological Endocrinology ,
Senior Director Ri Governance ,
Senior Director ,
Associate Professor ,
Medical Center ,
Senior Researcher ,
Project Co Ordinator ,
Radboud University Hospital ,
Pharma Solutions ,
Scientific Advice Meeting ,
Good Clinical Practices ,
Trial Regulation ,
Member States ,
Statistical Manual ,
Mental Disorders ,
Spring Life Sciences Communication ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Personnel Announcements ,
comparemela.com © 2020. All Rights Reserved.